foxo4-dri senolytic peptide human trials induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation FOXO4-DRI: The Senolytic Peptide That

A handful of peptides carry full FDA approval for specific uses, including the GLP-1 medications semaglutide and tirzepatide for weight and metabolic health, and tesamorelin

Administration is straightforward

Co-occurring deficiencies: you might also need support with iron, vitamin D, or folate

We're having a conversation about peptide therapy in the context of a broader plan, which may include a GLP-1 medication, hormone optimization, strength training, and nutritional restructuring

In one study of perceptions of long-acting injections (LAIs) compared to pills, for example, the perceived advantage for LAI over pills and the belief about the better efficiency of LAI were the main factors that drove the preference for LAI